ATE250413T1 - 2-aminotetraline zur behandlung von glaukom - Google Patents

2-aminotetraline zur behandlung von glaukom

Info

Publication number
ATE250413T1
ATE250413T1 AT00956296T AT00956296T ATE250413T1 AT E250413 T1 ATE250413 T1 AT E250413T1 AT 00956296 T AT00956296 T AT 00956296T AT 00956296 T AT00956296 T AT 00956296T AT E250413 T1 ATE250413 T1 AT E250413T1
Authority
AT
Austria
Prior art keywords
aminotetraline
glaucoma
treatment
sub
racemic
Prior art date
Application number
AT00956296T
Other languages
English (en)
Inventor
Stefano Bongrani
Roberta Razzetti
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE250413T1 publication Critical patent/ATE250413T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00956296T 1999-07-30 2000-07-26 2-aminotetraline zur behandlung von glaukom ATE250413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001713A IT1313583B1 (it) 1999-07-30 1999-07-30 Derivati 2-amminotetralinici per la terapia del glaucoma.
PCT/EP2000/007184 WO2001008667A2 (en) 1999-07-30 2000-07-26 2-aminotetralin derivatives for the therapy of glaucoma

Publications (1)

Publication Number Publication Date
ATE250413T1 true ATE250413T1 (de) 2003-10-15

Family

ID=11383465

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956296T ATE250413T1 (de) 1999-07-30 2000-07-26 2-aminotetraline zur behandlung von glaukom

Country Status (17)

Country Link
US (1) US6953813B1 (de)
EP (1) EP1200079B1 (de)
JP (1) JP2003505499A (de)
CN (1) CN1170532C (de)
AT (1) ATE250413T1 (de)
AU (1) AU778148B2 (de)
CA (1) CA2379778A1 (de)
CZ (1) CZ2002358A3 (de)
DE (1) DE60005525T2 (de)
ES (1) ES2207544T3 (de)
HK (1) HK1048594A1 (de)
HU (1) HUP0202098A3 (de)
IT (1) IT1313583B1 (de)
NO (1) NO20020475L (de)
PL (1) PL364794A1 (de)
WO (1) WO2001008667A2 (de)
ZA (1) ZA200200787B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
US7829587B2 (en) 2008-01-09 2010-11-09 Allergan, Inc. Substituted 2-aminotetralin derivatives as selective alpha 2B agonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794872B (en) * 1978-09-20 1980-11-26 Schering Corp A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
US5314916A (en) * 1993-04-19 1994-05-24 Alcon Laboratories, Inc. B2 adrenegic agonists and use thereof in the treatment of glaucoma
IT1275935B1 (it) * 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari

Also Published As

Publication number Publication date
JP2003505499A (ja) 2003-02-12
IT1313583B1 (it) 2002-09-09
NO20020475L (no) 2002-03-13
ITMI991713A1 (it) 2001-01-30
HK1048594A1 (zh) 2003-04-11
DE60005525D1 (de) 2003-10-30
ITMI991713A0 (it) 1999-07-30
HUP0202098A2 (en) 2002-10-28
PL364794A1 (en) 2004-12-13
CN1364081A (zh) 2002-08-14
DE60005525T2 (de) 2004-04-22
CN1170532C (zh) 2004-10-13
ES2207544T3 (es) 2004-06-01
AU6829300A (en) 2001-02-19
NO20020475D0 (no) 2002-01-29
WO2001008667A2 (en) 2001-02-08
EP1200079B1 (de) 2003-09-24
EP1200079A2 (de) 2002-05-02
HUP0202098A3 (en) 2003-08-28
CZ2002358A3 (cs) 2002-04-17
US6953813B1 (en) 2005-10-11
CA2379778A1 (en) 2001-02-08
ZA200200787B (en) 2003-03-26
AU778148B2 (en) 2004-11-18
WO2001008667A3 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
SE9903760D0 (sv) New compounds
SE0104334D0 (sv) Therapeutic agents
SE9701144D0 (sv) Novel compounds, their use and preparation
ATE383339T1 (de) Amin-derivate zur behandlung von apoptosis
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ATE250413T1 (de) 2-aminotetraline zur behandlung von glaukom
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
DE69525633T2 (de) Chinoxalinderivate und ihre therapeutische verwendbarkeit
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
SE9900190D0 (sv) New compounds
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
ATE88460T1 (de) Verbindungen zur behandlung von harninkontinenz.
ATE100439T1 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE69902142T2 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200079

Country of ref document: EP

REN Ceased due to non-payment of the annual fee